---
layout: minimal-medicine
title: Flecainide
---

# Flecainide
### Generic Name
Flecainide

### Usage

Flecainide is a class Ic antiarrhythmic medication primarily used for the rapid control or short-term prevention of various arrhythmias (irregular heartbeats).  Its main applications include:

* **Ventricular tachyarrhythmias:**  These are rapid heart rhythms originating in the ventricles (lower chambers of the heart). Flecainide helps control these potentially life-threatening arrhythmias.
* **Paroxysmal atrial fibrillation/flutter (PAF):** This involves rapid and irregular heartbeats originating in the atria (upper chambers). Flecainide is used when PAF causes disabling symptoms.
* **Supraventricular arrhythmias due to pre-excitation syndromes:** Conditions like Wolff-Parkinson-White syndrome cause abnormal electrical pathways in the heart, leading to rapid heartbeats. Flecainide can help manage these arrhythmias.
* **Prevention of recurrent PAF and PSVT:**  Flecainide can prevent the recurrence of PAF and paroxysmal supraventricular tachycardias (PSVT), a type of rapid heartbeat originating above the ventricles, in individuals experiencing disabling symptoms.
* **Prevention of life-threatening ventricular tachyarrhythmias:** In patients without underlying structural heart disease, Flecainide can help prevent potentially fatal rapid ventricular rhythms.

While not its primary use, Flecainide is sometimes used off-label (meaning not officially approved for this purpose) for conditions such as sustained fetal tachycardia (rapid fetal heartbeat) and ventricular premature beats (extra heartbeats originating in the ventricles).


### Dosage

Dosage varies significantly depending on the type and severity of the arrhythmia, the patient's age, weight, and renal or hepatic function.  It's crucial to follow a doctor's specific instructions.  Here's a general overview; **this information should not be used in place of a doctor's prescription:**

**Adults:**

* **Intravenous (IV):** Dosage is typically calculated based on body weight (mg/kg), with careful monitoring and adjustments based on the patient's response and potential side effects.  Administration must be slow to minimize adverse events.
* **Oral:**  Starting doses typically range from 50-100 mg twice daily, and can be adjusted upwards in increments over several days, as directed by the physician, based on the condition being treated and response to treatment, with a maximum daily dose varying depending on the specific arrhythmia being treated.  

**Children:**

Pediatric dosing is complex and requires careful calculation based on body surface area (BSA) or weight (mg/kg). It is crucial to follow a physician's guidance precisely.


**Dosage Adjustments:**

Dosage adjustments are necessary for patients with kidney (renal) or liver (hepatic) impairment.  Individuals with impaired organ function may require lower doses or less frequent administration to prevent drug accumulation and adverse effects.  Regular blood tests to monitor drug levels may be recommended.

**Important Note:**  This information is for general understanding only.  Precise dosage and administration must be determined by a healthcare professional based on individual patient needs and ongoing monitoring.

### Side Effects

Flecainide can cause several side effects, ranging from mild to serious. Common side effects include:

* Dizziness
* Visual disturbances (blurred vision, double vision)
* Nausea
* Headache
* Fatigue
* Constipation
* Dyspnea (shortness of breath)

Less common but more serious side effects can include:

* Proarrhythmic effects (worsening of arrhythmias, potentially life-threatening)
* Conduction disturbances (problems with electrical signals in the heart)
* Heart failure
* Allergic reactions (rash, itching, swelling)


If any adverse effects occur, immediately contact a healthcare provider.

### How it Works

Flecainide is a class Ic antiarrhythmic drug. It works by blocking the fast inward sodium current in heart muscle cells, reducing the excitability of the heart. This slows the conduction of electrical impulses through the heart and prolongs the refractory period (the time during which the heart muscle cannot be stimulated). By slowing the electrical signals, and making it harder to trigger abnormal heartbeats, Flecainide helps to restore a normal rhythm.


### Precautions

* **Contraindications:** Flecainide is contraindicated (should not be used) in individuals with certain heart conditions, such as severe heart block, cardiogenic shock, or hypersensitivity to flecainide.
* **Drug Interactions:** Flecainide interacts with many other medications. Consult a doctor or pharmacist about potential interactions before taking flecainide alongside other drugs.
* **Pregnancy and Breastfeeding:** Flecainide is a pregnancy category C drug. Use during pregnancy should be carefully evaluated.  The drug is excreted in breast milk. Discuss risks and benefits with a physician if breastfeeding.
* **Renal and Hepatic Impairment:** Reduced doses and careful monitoring are crucial for patients with kidney or liver disease.
* **Electrolyte Imbalances:**  Correcting electrolyte abnormalities (like low potassium) before and during treatment is essential.

### FAQs

* **Q: Can I take Flecainide with alcohol?**  A: It's best to avoid alcohol while on Flecainide, as it can interact negatively.  Discuss this with your doctor or pharmacist.
* **Q: How should I store Flecainide?** A: Store Flecainide as directed on the label, usually at room temperature, away from moisture and light.
* **Q: What if I miss a dose?**  A:  Do not double the next dose. Consult your doctor or pharmacist about how to proceed.
* **Q: How long will it take to feel better?** A:  The time to notice improvement will vary, depending on individual circumstances and the condition being treated.  It's essential to continue the treatment as directed.
* **Q: Can I stop taking Flecainide abruptly?** A:  No, stopping Flecainide abruptly can be harmful.  Always follow the doctor's instructions for tapering off the medication.

**Disclaimer:** This information is intended for general knowledge and does not constitute medical advice. Always consult a healthcare professional before starting or stopping any medication, including Flecainide.  The information provided here is not exhaustive.  Always consult the medication's official prescribing information for complete details.
